These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34689796)

  • 21. Development of weight and age-based dosing of daily primaquine for radical cure of vivax malaria.
    Taylor WR; Hoglund RM; Peerawaranun P; Nguyen TN; Hien TT; Tarantola A; von Seidlein L; Tripura R; Peto TJ; Dondorp AM; Landier J; H Nosten F; Smithuis F; Phommasone K; Mayxay M; Kheang ST; Say C; Neeraj K; Rithea L; Dysoley L; Kheng S; Muth S; Roca-Feltrer A; Debackere M; Fairhurst RM; Song N; Buchy P; Menard D; White NJ; Tarning J; Mukaka M
    Malar J; 2021 Sep; 20(1):366. PubMed ID: 34503519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imported tertian malaria resistant to primaquine.
    Na DJ; Han JD; Cha DY; Song IK; Choi HW; Chung EA; Park CW; Choi JS
    Korean J Intern Med; 1999 Jul; 14(2):86-9. PubMed ID: 10461431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primaquine treatment and relapse in Plasmodium vivax malaria.
    Rishikesh K; Saravu K
    Pathog Glob Health; 2016; 110(1):1-8. PubMed ID: 27077309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primaquine for preventing relapse in people with Plasmodium vivax malaria treated with chloroquine.
    Galappaththy GN; Tharyan P; Kirubakaran R
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD004389. PubMed ID: 24163057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasmodium vivax infections in U.S. Army troops: failure of primaquine to prevent relapse in studies from Somalia.
    Smoak BL; DeFraites RF; Magill AJ; Kain KC; Wellde BT
    Am J Trop Med Hyg; 1997 Feb; 56(2):231-4. PubMed ID: 9080885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of the efficacy of 8 weeks of primaquine for the prevention of relapse in vivax malaria patients using SSCP-PCR and sequencing in South and South-East Iran, 2008-2011.
    Miahipour A; Keshavarz H; Heidari A; Raeisi A; Rezaeian M; Rezaei S
    Trans R Soc Trop Med Hyg; 2013 Jul; 107(7):420-6. PubMed ID: 23694816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Directly-observed therapy (DOT) for the radical 14-day primaquine treatment of Plasmodium vivax malaria on the Thai-Myanmar border.
    Takeuchi R; Lawpoolsri S; Imwong M; Kobayashi J; Kaewkungwal J; Pukrittayakamee S; Puangsa-art S; Thanyavanich N; Maneeboonyang W; Day NP; Singhasivanon P
    Malar J; 2010 Nov; 9():308. PubMed ID: 21040545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mass radical treatment of a group of foreign workers to mitigate the risk of re-establishment of malaria in Sri Lanka.
    Marasinghe MM; Karunasena VM; Seneratne AS; Herath HDB; Fernando D; Wickremasinghe R; Mendis KN; Ranaweera D
    Malar J; 2020 Sep; 19(1):346. PubMed ID: 32977809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recurrence rate of vivax malaria in the Republic of Korea.
    Moon KT; Kim YK; Ko DH; Park I; Shin DC; Kim C
    Trans R Soc Trop Med Hyg; 2009 Dec; 103(12):1245-9. PubMed ID: 19041109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Several Plasmodium vivax relapses after correct primaquine treatment in a patient with impaired cytochrome P450 2D6 function.
    Martin Ramírez A; Lombardia González C; Soler Maniega T; Gutierrez Liarte Á; Domingo García D; Lanza Suárez M; Bernal Fernández MJ; Rubio JM
    Malar J; 2020 Jul; 19(1):259. PubMed ID: 32680522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of two short-course primaquine regimens for the treatment and radical cure of Plasmodium vivax malaria in Thailand.
    Pukrittayakamee S; Imwong M; Chotivanich K; Singhasivanon P; Day NP; White NJ
    Am J Trop Med Hyg; 2010 Apr; 82(4):542-7. PubMed ID: 20348496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantifying and preventing Plasmodium vivax recurrences in primaquine-untreated pregnant women: An observational and modeling study in Brazil.
    Corder RM; de Lima ACP; Khoury DS; Docken SS; Davenport MP; Ferreira MU
    PLoS Negl Trop Dis; 2020 Jul; 14(7):e0008526. PubMed ID: 32735631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CYP2D6 activity and the risk of recurrence of Plasmodium vivax malaria in the Brazilian Amazon: a prospective cohort study.
    Brasil LW; Rodrigues-Soares F; Santoro AB; Almeida ACG; Kühn A; Ramasawmy R; Lacerda MVG; Monteiro WM; Suarez-Kurtz G
    Malar J; 2018 Feb; 17(1):57. PubMed ID: 29390987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monitoring of clinical efficacy and in vitro sensitivity of Plasmodium vivax to chloroquine in area along Thai Myanmar border during 2009-2010.
    Muhamad P; Ruengweerayut R; Chacharoenkul W; Rungsihirunrat K; Na-Bangchang K
    Malar J; 2011 Feb; 10():44. PubMed ID: 21324161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recurrent Plasmodium vivax malaria due to dose-dependent primaquine resistance: a case report.
    Kristensen KL; Dragsted UB
    Scand J Infect Dis; 2014 Jan; 46(1):63-5. PubMed ID: 23957539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regional differences in the response of Plasmodium vivax malaria to primaquine as anti-relapse therapy.
    Goller JL; Jolley D; Ringwald P; Biggs BA
    Am J Trop Med Hyg; 2007 Feb; 76(2):203-7. PubMed ID: 17297026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Directly observed therapy with primaquine to reduce the recurrence rate of plasmodium vivax infection along the Thai-Myanmar border.
    Maneeboonyang W; Lawpoolsri S; Puangsa-Art S; Yimsamran S; Thanyavanich N; Wuthisen P; Prommongkol S; Chaimongkul W; Rukmanee P; Rukmanee N; Chavez IF; Buchachart K; Krudsood S; Singhasivanon P
    Southeast Asian J Trop Med Public Health; 2011 Jan; 42(1):9-18. PubMed ID: 21323159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-dose primaquine regimens against relapse of Plasmodium vivax malaria.
    Krudsood S; Tangpukdee N; Wilairatana P; Phophak N; Baird JK; Brittenham GM; Looareesuwan S
    Am J Trop Med Hyg; 2008 May; 78(5):736-40. PubMed ID: 18458306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A clinical tool to predict Plasmodium vivax recurrence in Malaysia.
    Mat Ariffin N; Islahudin F; Kumolosasi E; Makmor-Bakry M
    BMC Infect Dis; 2017 Dec; 17(1):759. PubMed ID: 29216842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adherence to 7-day primaquine treatment for the radical cure of P. vivax in the Peruvian Amazon.
    Grietens KP; Soto V; Erhart A; Ribera JM; Toomer E; Tenorio A; Montalvo TG; Rodriguez H; Cuentas AL; D'Alessandro U; Gamboa D
    Am J Trop Med Hyg; 2010 Jun; 82(6):1017-23. PubMed ID: 20519594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.